Moleculin Biotech, Inc. Proceeds from Issuance or Sale of Equity
Moleculin Biotech, Inc. (MBRX) reported Proceeds from Issuance or Sale of Equity of $4.66 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2024-11-08
- 2024-09-30: Proceeds from Issuance or Sale of Equity 9 month $4.66M.
- 2023-09-30: Proceeds from Issuance or Sale of Equity 9 month $211.00K.
- 2018-06-30: Proceeds from Issuance or Sale of Equity 1 month $2.30M.
- 2018-02-16: Proceeds from Issuance or Sale of Equity $9.00M.
| Period end | Proceeds from Issuance or Sale of Equity | Proceeds from Issuance or Sale of Equity 1 month | Proceeds from Issuance or Sale of Equity 9 month |
|---|---|---|---|
| 2024-09-30 | $4.66M 10-Q · filed 2024-11-08 | ||
| 2023-09-30 | $211.00K 10-Q · filed 2024-11-08 | ||
| 2018-06-30 | $2.30M 10-Q · filed 2019-11-12 | ||
| 2018-02-16 | $9.00M 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |